Skip to main content
Premium Trial:

Request an Annual Quote

Allele Biotech Stem Cells

Allele Biotech has produced its initial batch of six induced pluripotent stem cell (iPSC) lines. The firm's iPSCs were created using its mRNA technologies, with full cGMP monitoring and documentation starting from donor consent, screening, and tissue biopsy.  In addition to iPSC generation and differentiation, customers can use Allele's mRNA platform to engineer human iPSC s in a one-time genetic modification event to create a clonal iPSC line that can be developed into a master cell bank.